Growth Metrics

Angiodynamics (ANGO) Cash from Investing Activities (2016 - 2026)

Angiodynamics' Cash from Investing Activities history spans 17 years, with the latest figure at -$1.5 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 52.74% year-over-year to -$1.5 million; the TTM value through Feb 2026 reached -$7.3 million, up 26.18%, while the annual FY2025 figure was -$10.2 million, 108.23% down from the prior year.
  • Cash from Investing Activities reached -$1.5 million in Q1 2026 per ANGO's latest filing, up from -$1.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $98.4 million in Q3 2023 to a low of -$3.8 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is $5.5 million, with a median of -$2.1 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: surged 2852.85% in 2023, then crashed 110.85% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$2.5 million in 2022, then grew by 28.17% to -$1.8 million in 2023, then fell by 9.37% to -$2.0 million in 2024, then grew by 17.34% to -$1.6 million in 2025, then increased by 7.03% to -$1.5 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Cash from Investing Activities are -$1.5 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025).